Charleston News Online

Adrenocortical Carcinoma (ACC) Market Insights, Epidemiology, and Market Forecast-2030

Adrenocortical Carcinoma (ACC) Market Insights, Epidemiology, and Market Forecast-2030

March 16
21:26 2020

(Albany, US) DelveInsight has launched a new report on Adrenocortical Carcinoma Market Insights, Epidemiology and Market Forecast-2030

DelveInsight’s “Adrenocortical Carcinoma Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Adrenocortical Carcinoma, historical and forecasted epidemiology as well as the Adrenocortical Carcinoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

According to the National Cancer Institute, Adrenocortical Carcinoma (ACC) is rare cancer that originates in the outer layer of the adrenal gland. ACC is also called cancer of the adrenal cortex. A tumor of the adrenal cortex may be functioning (produces surplus hormones than usual) or nonfunctioning (does not produce surplus hormones than usual). Most adrenocortical tumors are functioning. 

 

Request for:-  Free Adrenocortical Carcinoma Sample Page

 

Adrenocortical Carcinoma Epidemiology 

The Adrenocortical Carcinoma epidemiology division provide insights about historical and current Adrenocortical Carcinoma patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

 

Some of the Report Key facts:-

        1. According to the retrospective review conducted by Aspinall et al. titled “How is Adrenocortical Cancer being Managed in the UK?,” the incidence of ACC is 0.5‒2 per million per year.

        2. According to the study by Johanssen et al. titled “Deficits in the Management of Patients With Adrenocortical Carcinoma in Germany,” the incidence of ACC is one per million population, and females are more frequently affected than males, with a female:male ratio of 1.5 : 1.

  

Report Key Benefits

1. Adrenocortical Carcinoma market report covers a descriptive overview and comprehensive insight of the Adrenocortical Carcinoma epidemiology Adrenocortical Carcinoma market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. Adrenocortical Carcinoma market report provides insights on the current and emerging therapies. 

3. Adrenocortical Carcinoma market report offers a global historical and forecasted market covering drug outreach in 7 MM.

4. Adrenocortical Carcinoma market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Cold Agglutinin Disease market.

 

“The emerging therapies for the treatment of Adrenocortical Carcinoma include Cabozantinib, EO2401, and others. The current research on the combination cytotoxic drugs will lead to the more emerging therapies”

 

Some of the key companies working on CAD that are given below-

  1. Bristol-Myers Squibb Pharmaceutical Co.
  2. Exelixis Pharmaceuticals
  3. Enterome Pharmaceuticals

 

Name of covered Drugs are given below.

  1. Lysodren
  2. Cabozantinib
  3. EO2401

 

Table of Content-

1. Key Insights

2. Executive Summary of Adrenocortical Carcinoma

3. Competitive Intelligence Analysis for Adrenocortical Carcinoma

4. Adrenocortical Carcinoma: Market Overview at a Glance

5. Adrenocortical Carcinoma: Disease Background and Overview

6. Patient Journey

7. Adrenocortical Carcinoma Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Adrenocortical Carcinoma Treatment

11. Marketed Products

12. Emerging Therapies

13. Adrenocortical Carcinoma: Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Adrenocortical Carcinoma

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this Adrenocortical Carcinoa market report?

  • The report will help in developing business strategies by understanding trends shaping and driving the Adrenocortical Carcinoma market
  • To understand the future market competition in the Adrenocortical Carcinoma market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Adrenocortical Carcinoma in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Adrenocortical Carcinoma market
  • To understand the future market competition in the Adrenocortical Carcinoma market

Related Reports:-

1. Adrenocortical Carcinoma Epidemiology Forecast to 2030

2. Adrenocortical Carcinoma Pipeline Insights, 2020

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NEVADA 89107
Country: United States
Website: https://www.delveinsight.com/

About Author

admin

admin

Related Articles